Welcome : Guest

SYGNIS AG (Germany) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about SYGNIS AG, which is principally involved in Biotechnology Business. Illustrated with 54 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-38264
Price: $2700
Company Type: Public
Pages: 56
Date: November 2016
Market Data Tables: 54

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Sygnis AG’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Spain, Germany, and USA......3
Table 2: Sygnis Pharma AG’s Sales by Product Segment Worldwide (2014) in Percentage for Caco-2, Double Switch, QualiPhi and Services/others......4
Biotechnology......5
Table 3: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......5
Table 4: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......6
Biotesting (Outsourced)......7
Table 5: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......7
Biotechnology Drugs......8
Table 6: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......8
HIV Drugs......9
Table 7: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others* (Includes NNRTIs)......9
Table 8: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......10
Table 9: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......11
Table 10: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......12
DNA Carrier Testing......13
Table 11: DNA Carrier Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......13
DNA & Gene Chips (Microarray)......14
Table 12: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......14
Table 13: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......15
Table 14: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......16
Diagnostic Testing......17
Table 15: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......17
Table 16: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......18
Table 17: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......19
Table 18: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......20
Table 19: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......21
Table 20: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......22
Table 21: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......23
Table 22: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......24
Molecular Diagnostics......25
Table 23: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......25
Table 24: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......26
Table 25: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......27
Table 26: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......28
Table 27: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......29
Table 28: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......30
Table 29: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......31
Table 30: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......32
Table 31: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......33
Table 32: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......34
Table 33: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......35
Table 34: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......36
Table 35: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......37
Table 36: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......38
Table 37: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......39
Table 38: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......40
Table 39: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......41
Table 40: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......42
Table 41: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......43
Table 42: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......44
Biotechnology......45
Table 43: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......45
Table 44: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......46
Table 45: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......47
Outsourced Biotesting......48
Table 46: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......48
Colony-Stimulating Factor (GCSF)......49
Table 47: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......49
Diagnostic Imaging Equipment......50
Table 48: Market Shares of Leading Diagnostic Imaging Equipment Providers Worldwide (2015) - Percentage Breakdown by Value for Carestream Health, Inc., General Electric Co., Koninklijke Philips N.V., Siemens AG, Toshiba Corporation, and Others......50
Diagnostic Ultrasound......51
Table 49: Market Shares of Leading Diagnostic Ultrasound Manufacturers by Value Sales in Japan (2014) - Percentage Share Breakdown For GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, and Others......51
Diagnostic Testing......52
Table 50: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......52
Molecular Diagnostics......53
Table 51: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......53
Table 52: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......54
Table 53: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......55
Cell Biology Products......56
Table 54: Market Shares of Leading Cell Biology Products Manufacturers in the US (2015) - Percentage Breakdown by Value for Life Technologies Corporation, and Others......56